title: The effect of taurine on the toll-like receptors/nuclear factor kappa B (TLRs/NF-κB) signaling pathway in Streptococcus uberis-induced mastitis in rats.
abstract: To investigate whether taurine ameliorates mammary damage in a rat model of S. uberis mastitis by suppressing inflammation related to the toll-like receptors/nuclear factor kappa B (TLRs/NF-κB) signaling pathway. Starting on gestation day 14 and continuing until parturition, 100 mg/kg of taurine (group TS) or an equal volume of physiological saline (group CS) was administered daily to rats. Seventy-two hours after parturition, rats were infused with 100 cfu of S. uberis into each of 2 mammary glands. The resultant inflammation, evidenced by swelling, degeneration of secretory epithelium, increased tissue loss and neutrophil (PMN) infiltration was observed. Pretreatment with taurine attenuated inflammatory changes and significantly decreased mRNA expression of TLR-2 (8 h post S. uberis-injection, PI), NF-κB p65 (16 h and 24 h PI), and NF-κB DNA binding activity (16 h PI). Tumor necrosis factor (TNF)-α and inducible nitric oxide synthase (iNOS) levels were also decreased. Significant differences (P<0.05) were present at 24 h and 48 h PI for TNF-α and at 16 h PI for iNOS. TLR-4 mRNA expression was increased by taurine administration and significant differences were observed at 8h, 16 h and 24 h PI. These results suggest that the in vivo relationship of immunomodulatory reagents with TLRs is complex. Taurine may modulate inflammatory injury induced by S. uberis in mammary glands though TLR-2 and TLR-4. Suppression of inflammation may be related to TLRs/NF-κB and may be one mechanism of taurine action in controlling S. uberis mastitis.
authors: College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China. mjf171647@126.com
authors: Jinfeng
authors: J
authors: Miao
authors: Liuhai
authors: L
authors: Zheng
authors: Jinqiu
authors: J
authors: Zhang
authors: Zili
authors: Z
authors: Ma
authors: Wei
authors: W
authors: Zhu
authors: Sixiang
authors: S
authors: Zou
mesh_terms: D000818:Animals; D024202:Electrophoretic Mobility Shift Assay; D005260:Female; D005865:Gestational Age; D008321:Mammary Glands, Animal / Q000187:drug effects* / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D008413:Mastitis / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D060888:Real-Time Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects; D013290:Streptococcal Infections / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D013654:Taurine / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D051195:Toll-Like Receptor 2 / Q000096:biosynthesis / Q000276:immunology; D051197:Toll-Like Receptor 4 / Q000096:biosynthesis / Q000276:immunology; D051193:Toll-Like Receptors / Q000096:biosynthesis / Q000276:immunology*; D051996:Transcription Factor RelA / Q000096:biosynthesis / Q000276:immunology*
chemical_list: C495343:Tlr2 protein, rat; C495347:Tlr4 protein, rat; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4; D051193:Toll-Like Receptors; D051996:Transcription Factor RelA; D013654:Taurine